Broderick Brian C trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,910 shares of the company’s stock after selling 514 shares during the quarter. Broderick Brian C’s holdings in Colgate-Palmolive were worth $725,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp grew its stake in Colgate-Palmolive by 0.9% during the first quarter. Bank of New York Mellon Corp now owns 18,821,363 shares of the company’s stock worth $1,377,537,000 after buying an additional 169,798 shares in the last quarter. First Eagle Investment Management LLC grew its stake in Colgate-Palmolive by 2.6% during the first quarter. First Eagle Investment Management LLC now owns 4,782,281 shares of the company’s stock worth $350,015,000 after buying an additional 122,983 shares in the last quarter. TIAA CREF Investment Management LLC grew its stake in Colgate-Palmolive by 84.2% during the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock worth $333,380,000 after buying an additional 2,082,262 shares in the last quarter. Legal & General Group Plc grew its stake in Colgate-Palmolive by 5.1% during the first quarter. Legal & General Group Plc now owns 4,293,890 shares of the company’s stock worth $314,276,000 after buying an additional 208,905 shares in the last quarter. Finally, Swiss National Bank grew its stake in Colgate-Palmolive by 22.2% during the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock worth $268,393,000 after buying an additional 666,400 shares in the last quarter. 73.16% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This article was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/09/12/broderick-brian-c-sells-514-shares-of-colgate-palmolive-company-cl.html.

Colgate-Palmolive Company (NYSE:CL) traded down 0.1033% during midday trading on Tuesday, reaching $71.9456. 630,893 shares of the company traded hands. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27. The company has a market capitalization of $63.37 billion, a price-to-earnings ratio of 26.7356 and a beta of 0.80. The stock’s 50 day moving average is $71.61 and its 200 day moving average is $73.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. Colgate-Palmolive’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.70 earnings per share. On average, equities analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 35,000 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $71.52, for a total value of $2,503,200.00. Following the completion of the sale, the insider now owns 201,411 shares of the company’s stock, valued at $14,404,914.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the sale, the insider now directly owns 53,022 shares of the company’s stock, valued at approximately $3,839,323.02. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 221,802 shares of company stock worth $15,983,976. 1.02% of the stock is owned by company insiders.

CL has been the topic of a number of analyst reports. Bank of America Corporation increased their price objective on shares of Colgate-Palmolive from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, May 31st. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective on the stock in a research note on Tuesday, July 4th. Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. BidaskClub downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Finally, Jefferies Group LLC reiterated a “hold” rating and set a $76.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, May 17th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company’s stock. Colgate-Palmolive has an average rating of “Hold” and a consensus price target of $75.82.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.